Ontuxizumab Biosimilar – Anti-CD248 mAb – Research Grade

Reference:
Size

,

Isotype

IgG1, kappa

Brand

Product type

Clonality

Expression system

Applications

,

Product nameOntuxizumab Biosimilar - Anti-CD248 mAb - Research Grade
SourceCAS 946415-62-9
SpeciesChimeric,Humanized
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsOntuxizumab,MORAb-004,CD248,anti-CD248
ReferencePX-TA1346
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody

Description of Ontuxizumab Biosimilar - Anti-CD248 mAb - Research Grade

General information on Anti-CD248[Homo sapiens] (Ontuxizumab) Monoclonal Antibody

Ontuxizumab monoclonal antibody targets CD248. It has been used in the treatment of cancer.

SDS-PAGE for Ontuxizumab Biosimilar – Anti-CD248 mAb

Ontuxizumab Biosimilar – Anti-CD248 mAb on SDS-PAGE under non-reducing (left figure) and reducing (right figure) conditions. The gel was stained overnight with Coomassie Blue. The purity of the antibody is superior than 90 %.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Ontuxizumab Biosimilar – Anti-CD248 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

CD2 Recombinant Protein
Antigen

CD2 Recombinant Protein

PX-P4073 500$

Contact us

Send us a message from the form below







    Cart (0 Items)

    Your cart is currently empty.

    View Products